Page last updated: 2024-11-03

proglumide and Adenocarcinoma, Papillary

proglumide has been researched along with Adenocarcinoma, Papillary in 1 studies

Proglumide: A drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers.
proglumide : A racemate composed of equal amounts of (R)- and (S)-proglumide. A non-selective CCK antagonist that was used primarily for treatment of stomach ulcers, but has been replaced by newer drugs.
N(2)-benzoyl-N,N-dipropyl-alpha-glutamine : A dicarboxylic acid monoamide obtained by formal condensation of the alpha-carboxy group of N-benzoylglutamic acid with dippropylamine.

Adenocarcinoma, Papillary: An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ogura, Y1
Matsuda, S1
Itho, M1
Sasaki, H1
Tanigawa, K1
Shimomura, M1

Other Studies

1 other study available for proglumide and Adenocarcinoma, Papillary

ArticleYear
Inhibitory effect of loxiglumide (CR 1505), a cholecystokinin receptor antagonist, on N-nitrosobis(2-oxopropyl) amine-induced biliary carcinogenesis in Syrian hamsters.
    World journal of surgery, 2002, Volume: 26, Issue:3

    Topics: Adenocarcinoma, Papillary; Animals; Autoradiography; Biliary Tract Neoplasms; Carcinogens; Cholecyst

2002